Related Experiment Videos
Abstract:
We observed three cases in which anti-M, undetectable in pretransfusion serum, was responsible for accelerated hemolysis of crossmatch-compatible red blood cells 5 to 15 days after transfusion. In each case, the direct antiglobulin test, which had been negative on pretransfusion testing, was weakly positive on the posttransfusion sample. Anti-M was identified in both the serum and eluate from the posttransfusion sample in two cases. In the third, anti-M could be identified only in the posttransfusion serum. Hemolysis was mild, and was not clinically suspected in any of these three patients until blood was requested for further transfusion. In one of the cases, the antibody was undetectable within a few weeks after the hemolytic episode. Destruction of transfused red blood cells by newly synthesized alloantibodies, particularly those of the Kidd system, is a familiar phenomenon to blood bankers. It is apparent from these studies that anti-M also can behave in this fashion.
Insights
Newly synthesized anti-M antibodies caused delayed, accelerated hemolysis of transfused red blood cells. This immune response, though mild, highlights a potential complication in transfusion medicine.
Area of Science:
- Transfusion Medicine
- Immunology
- Hematology
Background:
- Alloantibodies, particularly Kidd system antibodies, can cause delayed hemolytic transfusion reactions.
- The behavior of anti-M antibodies in post-transfusion hemolysis is less understood.
Observation:
- Three cases of delayed hemolytic reactions occurred 5-15 days post-transfusion.
- Direct antiglobulin tests were negative pre-transfusion but weakly positive post-transfusion.
- Anti-M antibodies were detected in post-transfusion samples, causing hemolysis of compatible red blood cells.
Findings:
- Newly synthesized anti-M antibodies can cause accelerated hemolysis of transfused red blood cells.
- Hemolysis was mild and often clinically unsuspected until subsequent transfusion requests.
- Anti-M antibodies may become undetectable weeks after the hemolytic event.
Implications:
- Anti-M should be considered in cases of delayed hemolytic transfusion reactions, even when initially undetectable.
- This finding expands the known spectrum of alloantibody behavior in transfusion medicine.
- Awareness of anti-M's potential for delayed hemolysis is crucial for patient safety.